Safety of use, efficacy and degree of parental satisfaction with the nasal aspirator Narhinel® in the treatment of nasal congestion in babies;Sicurezza d'uso, efficacia e grado di soddisfazione dei genitori con l'aspiratore nasale Narhinel® nel trattamento della congestione nasale dei bambini

Minerva Pediatrica

Volumn 59, Issue 4, 2007, Pages 315-326

  Casati, M ^a   Picca, M ^a   Marinello, R ^a   Quartarone, G ^b,c  

^a FIMP Lombardy   (Italy)

^b Medical Affairs Department   (Italy)

^c Novartis CH   (Italy)

Author keywords

Infant; Medical device; Nasal decongestants; Nasal obstruction

Indexed keywords

ARTICLE; CONSUMER; CONTROLLED STUDY; CRYING; DEVICE THERAPY; EPISTAXIS; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOUTH BREATHING; NOSE BREATHING; NOSE CONGESTION; NOSE SECRETION; OUTPATIENT; PEDIATRICIAN; POSTMARKETING SURVEILLANCE; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUESTIONNAIRE; RESTLESSNESS; RHINORRHEA; RISK ASSESSMENT; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

CHILD, PRESCHOOL; CONSUMER SATISFACTION; FEMALE; HUMANS; INFANT; MALE; NASAL OBSTRUCTION; PARENTS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; SUCTION;

EID: 35848959756     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Clement PAR, Bluestone CD, Gordts F, Lusk RP, Otten FW, Goossens H et al. Management of rhinosinusitis in children: Consensus Meeting, Brussels, September 13, 1996. Arch Otolaryngol Head Neck Surg 1998;124: 31-4.
2. Faden HS. Immunology of the middle ear: role of local and systemic antibodies in clearance of viruses and bacteria. Ann N Y Acad Sci 1997;830:49-61.
3. Bernstein JM, FadenHF, Dryja DM, Wactawski-Wende J. Microecology of the nasopharyngeal bacterial flora in otitis-prone e non otitis-prone children. Acta Otolaryngol 1993;113:88-92.
4. Garcia-Rodriguez JA, Fresnadillo Martinez MJ. Dynamics of nasopharyngeal colonisation by potential respiratory pathogens. J Antimicrob Chemiother 2002;50 Suppl S2:59-73.
5. Harrison LM, Morris JA, Telford DR, Brown SM, Jones K. The nasopharyngeal bacterial flora in infancy: effects of age, gender, season, viral upper respiratory tract infection and sleeping position. FEMS Immunol Med Microbiol 1999;25:19-28.
6. Veenhoven RH, Bogaert D, Shilder AG, Rijkers GT, Uiterwaal CS, Kiezebrink HH et al. Nasopharyngeal pneumococcal carriage after combined pneunococcal conjugate and polysaccharide vaccination in children with a history of recurrent AOM. Clin Infect Dis 2004;39:911-9.
7. Marchisio P, Claut I, Rognoni A, Esposito S, Bellussi L, Passali D et al. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent AOM and COME: implications for management. Pediatr Infect Dis J 2003;22:262-8.
8. Gasparoni A, Chirico G. L'ostruzione nasale nel neonato. Acta Neonatologica et Pediatrica 2004.
9. Monto AS. Epidemiology of viral respiratory infections. Am J Med 2002;112:4S-12S.
10. Parkin PC, Taylor CY, Petric, Schuh S, Goldbach M, Ipp M. Controlled study of respiratory viruses and wheezing. Arch Dis Child 2002;87:221-2.
11. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004;4:144-54.
12. Venelle M, Brander PE, Kingshott RN, Rees K, Warren PM, Keeling JW et al. Is there a familial association between obstructive sleep apnoea/hypopnoea and the sudden infant death syndrome? Thorax 2004;59:337-41.
13. Ghelfi D. Sleep apneas in children. Ther Umsch 2000;57:463-6
14. Gruppo di lavoro sui farmaci pediatrici (istituito presso l'AIFA) Decongestionanti nasali: nei bambini i rischi superano i benefici. Medico e Bambino 2007;26:309.
15. Smith MBH, Feldman W. Over the counter cold medication: a critical review of clinical trials between 1950 and 1991. JAMA 1993;269:2258-63.
16. Taverner D, Latte J. Nasal decongestionants for the common cold. Cochrane Database Syst Rev 2007;(1):CD001953.
17. Seppey M, Krayenbuhl M, Simmen D, Buvelot J-M, Pelloni R. Rhinomer pour la thérapie de la pathologie rhinosinusale. ORL Highlights 1995;2:20-4.
18. Traissac L, Bordenave L, Bareille R, Bacquey C, Courtes C. In vitro study of the effect of sea water by-products in the respiratory mucosa. Rev Soc Fr ORL 1995;32.
19. Tabary O, Muselet C, Yvin JC, Halley-Vanhove B, Puchelle E, Jacquot J. Physiomer reduces the chemokine interleukin-8 production by activated human respiratory epithelial cells. Eur Respir J 2001;18:1-6.